To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

OPDP Bulletins

  • OPA Bulletin - May 28, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA and Neighbourhood Pharmacies oppose government's proposal to extract $140 million annually from pharmacy
    • Last chance to register for conference - registration closes Thursday!
    • Discontinuation Notice - PrDepo-Provera® (medroxyprogesterone acetate, USP) 50 mg/mL in 1 x 5 mL Vial
    • Drug Supply Health System Alert: OncoTICE
    • IMPORTANT: Notification Regarding PrNORVASC® (amlodipine besylate) 10 mg tablets in bottles of 250.
    • Re-issuing Spring Issue of Ontario Pharmacist

    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • How-To: Ontario’s Pharmaceutical Opinion Program
    • Asthma Management: The Essentials

    • Summer's almost here! Time to get your Canada's Wonderland passes
    • Ask the Practice Support Network

    • Are you considering Joining a Local Area Network (LAN) or Wide Area Network (WAN)?

    • DDD Notice No. 19081 posted May 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – May 2019

  • OPA Bulletin - March 26, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Process Map and Pharmacy Tool for OHIP+
    • ICYMI: Empowering Canadian Pharmacy Practice
    • Pharmacy Experience Pharmacie 2019 is open for registration!
    • Research Study: The Ontario Digital Service and Ministry of Health and Long-Term Care
    • Canadian Federation of Pharmacy Campaign Drive 1 Million for 25
    • OPA Supports Broader Discussion on Impact of Removal of Private Label Ban

    • Implementing Smoking Cessation Services in the Pharmacy
    • Asthma Management: The Essentials
    • MedsCheck Refresh: Implementing the Revitalized Program

    • Last Call for OPA Awards
    • Ask the Customer Experience and Administration Team

    • OPA Secure Health Plan Q&A
    • It's Movie Ticket Time with COSECO!

    • DDD Notice No. 19057 posted March 20, 2019 Prescription Forgery Alert
    • DDD Notice No. 19058 posted March 21, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – March 2019
    • DDD Notice No. 19059 posted March 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms

    • Extraneal peritoneal dialysis solution - Advisory
    • Important Safety Information on DARZALEX (daratumumab) and Hepatitis B Virus Reactivation - Janssen Inc.

  • OPA Bulletin - November 20, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Pharmacy News
    • OPDP Notice No. 18145 posted November 16, 2018 Notice from the Executive Officer

    News from OPA
    • Membership and DIRC subscription campaigns open! Take advantage of early bird
    • Research and Advocacy
    • CPhA/OPA Conference - Pharmacy Experience Pharmacie (PxP) Call for Speakers
    • Ask the Customer Experience and Administration Team
    • Highlights in Professional Development​
    • OPA's PLI Insurance - Best-in-Class!

  • OPDP Notice No. 17109

    OPDP Notice No. 17109 posted September 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – September 2017 We are pleased to provide you with the Summary of Changes – September 2017 to Edition No. 42 of the Ontario Drug Benefit (ODB) …

    September 03, 2013
  • OPDP Notice No. 17108

    OPDP Notice No. 17108 posted September 21, 2017 Notice from the Executive Officer: Changes to Fentanyl Dispensing Ontario Public Drug Programs is committed to supporting the appropriate prescribing and dispensing of opioids and addressing the …

    September 03, 2013
  • OPDP BULLETINS August 23-29, 2017

    OPDP Notice No. 17100 posted August 23, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – August 2017 OPDP Notice No. 17101 posted August 23, 2017 Notice from the Executive Officer: Thyroid (Dessicated Thyroid) Delisting OPDP Notice …

    September 03, 2013
  • OPDP BULLETINS August 2 - 9, 2017

    OPDP Notice. 17096 posted August 3, 2017 Prescription Forgery Alert OPDP Notice No. 17097 posted August 3, 2017 Notice from the Executive Officer: Reimbursement and Claim Submissions for Mifepristone/Misoprostol (Mifegymiso) OPDP Notice No. 1 …

    September 03, 2013
  • OPDP BULLETINS July 26 - August 1, 2017

    OPDP Notice. 17092A posted July 28, 2017 Addendum to ODB Formulary – Edition 42, Summary of Changes – July 2017 OPDP Notice No.17095 posted August 1, 2017 Notice from the Executive Officer: Funding of filgrastim under the Ontario Drug Benefit …

    September 03, 2013
  • OPDP BULLETINS July 18-25, 2017

    OPDP Notice. 17091 posted July 20, 2017 E-FORMULARY OUTAGE NOTIFICATION TO ODP AGENCIES OPDP Notice. 17092 posted July 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – July 2017 OPDP Notice No. 17093 posted July 21, 2017 Notice …

    September 03, 2013
  • OPDP BULLETINS July 5-11, 2017

    OPDP Notice. 17082 posted July 5, 2017 CPSO Notices June 2017 - Release 1 of 2 OPDP Notice. 17083 posted July 5, 2017 CPSO Notices June 2017 - Release 2 of 2 OPDP Notice. 17084 posted July 7, 2017 E-FORMULARY OUTAGE NOTIFICATION TO ODP …

    September 03, 2013
  • OPDP BULLETINS June 28 - July 4, 2017

    OPDP Notice. 17080 posted June 30, 2017 Notice from the Executive Office OPDP Notice. 17080 posted June 30, 2017 Notice from the Executive OfficeNotice from the Executive OfficerJune 30, 2017 This notice is to advise health care …

    September 03, 2013
  • OPDP BULLETINS June 14-23, 2017

    OPDP Notice. 17069 posted June 14, 2017 CPSO Notices - March 2017, Release 1 of 2 OPDP Notice. 17070 posted June 14, 2017 CPSO Notices - March 2017, Release 2 of 2 OPDP Notice. 17071 posted June 15, 2017 CPSO Notices - April 2017, Release 1 …

    September 03, 2013
  • OPDP BULLETINS June 7-13, 2017

    OPDP Notice. 17067 posted June 09, 2017 CPSO Notice OPDP Notice. 17068 posted June 09, 2017 CPSO Notice OPDP Notice. 17067 posted June 09, 2017 CPSO NoticePlease be advised of the following public notices issued by the College of …

    September 03, 2013
  • OPDP BULLETINS MAY 31 - JUNE 6, 2017

    OPDP Notice No. 17066 posted June 2, 2017 Information Bulletin: Update on the Publicly Funded Influenza Vaccines for Ontario Pharmacies OPDP Notice No. 17066 posted June 2, 2017 Information Bulletin: Update on the Publicly Funded …

    September 03, 2013
  • OPDP BULLETINS MAY 24-30, 2017

    OPDP Notice No. 17061 posted May 24, 2017 Prescription Forgery Alert OPDP Notice No. 17062 posted May 24, 2017 Prescription Forgery Alert  OPDP Notice No. 17063 posted May 24, 2017 Prescription Forgery Alert  OPDP Notice No. 17064 posted …

    September 03, 2013
  • OPDP BULLETINS MAY 17-23, 2017

    OPDP Notice No. 17060 posted May 23, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – May 2017 SUMMARY OF PRODUCT CHANGES ODB FORMULARY – EDITION NO. 42, Summary of Changes – May 2017 SUMMARY OF PRODUCT CHANGES   We are pleased to …

    September 03, 2013
  • OPDP BULLETINS MAY 3-9, 2017

    OPDP Notice. 17056 posted May 05, 2017 CPSO Notice OPDP Notice. 17057 posted May 05, 2017 CPSO Notice OPDP Notice. 17056 posted May 05, 2017 CPSO Notice Please be advised of the following public notices issued by the College of Physicians …

    September 03, 2013
  • OPDP BULLETINS APRIL 26 - MAY 2, 2017

    Addendum to OPDP Notice No. 17051 (ODB Formulary – Edition 42, Summary of Changes – April 2017) OPDP Notice No. 17054 posted April 27, 2017 Notice from the Executive Officer OPDP Notice. 17055 posted April 28, 2017 Prescription …

    September 03, 2013
  • OPDP BULLETINS APRIL 19-25, 2017

    OPDP Notice No. 17051 posted April 20, 2017 ODB FORMULARY EDITION NO. 42 APRIL 2017 UPDATE SUMMARY OF PRODUCT CHANGES OPDP Notice No. 17053 posted April 21, 2017 Information Bulletin: Update on the Ontario Naloxone Program for Pharmacies …

    September 03, 2013
  • OPDP BULLETINS APRIL 5-11, 2017

    OPDP Notice. 17049 posted April 10, 2017 Prescription Forgery Alert Prescription Forgery Alert   A physician has notified the ministry that a prescription pad containing approximately 25 sheets has been taken from his office.  The physician’s …

    September 03, 2013
Back to top